A new innovation for the rapid identification of pathogens.
Quebec, August 7, 2025 – Bioeureka today unveiled a new method for rapid and low-cost pathogen identificationé using Artificial Intelligence.
In the realm of microbiological control, whether in specialized laboratories or within food production lines, the rapid and reliable identification of pathogens remains a critical challenge-essential for safety, regulatory compliance, and operational optimization. It is with this in mind that MicroSelect, an exclusive innovation by BioEureka, emerges as the new standard for selective culture media.
An Integrated Process: Three Selective Media in One Plate
Traditionally, accurately identifying the specific nature of a pathogen requires performing the same test across multiple separate culture media, increasing manipulations, the risk of error, and costs. MicroSelect simplifies this process: on a single Petri dish, three selective culture media are presented side by side – tryptic soy agar enriched with 5% sheep blood for broad growth, MacConkey Agar targeting Gram-negative bacteria, and Mannitol Salt Agar specialized for staphylococci and Gram-positive bacteria.
The process is designed for simplicity and robustness: the laboratory technician or quality manager in the factory simply applies a dilution of the sample to be tested on each section of the MicroSelect plate. In one motion, they unlock the potential for swift and differentiated identification of the most sought-after pathogens in food production or surveillance laboratories.
Unmatched Time and Cost Savings
After depositing the sample, the MicroSelect plate is incubated, typically at 37 °C (some pathogens require slightly different temperatures) for 12 to 24 hours. Following this brief incubation period, the technician prepares a slide from the culture and performs a Gram staining to obtain a clear image under the microscope.
This is where BioEureka’s second innovation comes into play: the Bioeureka software. Utilizing a high-resolution camera and advanced artificial intelligence, Bioeureka analyzes the slide in seconds, proposes an identification of the bacterial strain, and recommends biochemical tests to confirm the result. Unlike traditional practices where laboratories often must conduct a full battery of biochemical tests-costly in terms of time and consumables-the targeted recommendation from Bioeureka reduces validation to a single test, effectively eliminating most unnecessary steps.
Results in Less Than 24 Hours Instead of Several Days
The combination of MicroSelect and Bioeureka significantly reduces turnaround times: while sending a sample to an external laboratory often requires five days for identification, the BioEureka solution delivers a reliable and validated result autonomously in just 12 to 24 hours.
In summary, MicroSelect is much more than a new culture medium; it is the key to a new organization of microbiological control, focused on simplicity, efficiency, and cost reduction. Coupled with the Bioeureka software, it transforms the routine of quality teams and microbiologists, providing your business with a valuable edge in safety and innovation.
Ready to modernize pathogen management in your laboratory or production facility? Explore MicroSelect and Bioeureka today on our website-and propel your analyses into the next generation!
– Devien Durbano
Microbiologist, Lead Scientist
